Lilly to Expand its Manufacturing Facility in Puerto Rico
Eli Lilly and Company has unveiled plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in...
Lilly to Build $3B Manufacturing Facility in Netherlands
Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....
Lilly, NVIDIA Partner on AI Supercomputer for Drug Research
Eli Lilly and Company has revealed plans to construct what it calls the most powerful supercomputer ever built and operated by a pharmaceutical company,...
Novartis to Acquire Avidity Biosciences in $12 Billion Deal
Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...
Pharma Manufacturing Hubs in the Middle East
Middle East Pharma Hubs: Building Global-Standard Manufacturing Ecosystems
The pharmaceutical landscape across the Middle East is undergoing a remarkable transformation. What was once a region...
Pharma Cold Chain 4.0 and Smart Logistics
Pharma Cold Chain 4.0: Reinventing Temperature-Controlled Logistics
The pharmaceutical supply chain faces unprecedented challenges in delivering temperature-sensitive medicines safely and efficiently to patients worldwide. Biologics,...
Digital Transformation of Smart Pharma R&D Labs
Smart Labs of the Future: Digital Transformation in R&D Facilities
The pharmaceutical research and development laboratory stands at the epicenter of a profound digital transformation...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...